Abstract
Whole blood vitamin Q (ubiquinone), plasma vitamins Q and E(alpha-(a-)tocopherol) and free cholesterol (FC) were studied before(control or base-line value, sample I) and during open chest surgery andextracorporal circulation (samples II-IV) in 10 male IHD patients. Identityexisted between control whole blood and plasma ubiquinone. During surgery anincreased discrepancy with lower plasma vitamin Q levels were seen. Controlplasma vitamins Q, E and FC averaged 0.88 ± 0.16 (SE), 12.1 ±2.2 mg × 1-1 and 0.75 ± 0.15 g × 1-1. Corresponding molarvalues were 1.02 ± 0.17, 28.1 ± 5.1 µmol × 1-1 and1.94 ± 0.74 mmol × 1-1. Vitamin Q and E decreased continuouslyand averaged 0.64 mg × 1-1 in sample IV (0.74 µmol × 1-1,p < 0.001) and 9.4 mg × 1-1 in sample III (21.8 µmol ×1-1, p < 0.001). Hemolysis in all sample IV vials, ruined all vitamin Edeterminations. When normalized for FC (NQ and NE), decreases were found tobe 17 (IV) and 12% (III), respectively. Large interindividual variationsexisted. High control NQ and NE values allowed a larger antioxidant vitamindepletion. High NQ seemed also to be a prerequisite for NE depletion. Inaddition, signs indicated an active liver vitamin Q release for patientsrich in control antioxidant values. It was suggested that the antioxidantvitamin depletion did not prevent from radical trauma to membrane structurallipids (especially omega-3 fatty acids or vitamin F1), less membranefluidity, erythrocyte fragility and hemolysis.
Similar content being viewed by others
References
Kayden HJ, Silber R: Vitamin E deficiency in the abnormal autohemolysis of acanthocytosis. Trans Assoc Am Phys 78: 334–341, 1965
Yamamoto Y, Niki E, Kamiya Y, Miki M, Tamai H, Mino M: Free radical chain oxidation and hemolysis of erythrocytes by molecular oxygen and their inhibition by vitamin E. J Nutr Sci Vitaminol 32: 475–479, 1986
Cunnane SC, Ho S-Y, Dore-Duffy P, Ells KR, Horrobin DF: Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis [1–4]. Am J Clin Nutr 50: 801–806, 1989
Aslam M, Arif MJ, Rahman O: Red blood cell damage by wollastonite: In vitrostudy. J Appl Physiol 15: 27–31, 1995
Moen O, Fosse E, Braten J, Andersson C et al.: Roller and centrifugal pumps compared in vitrowith regard to haemolysis, granulocyte and compliment activation. Perfusion 9: 109–117, 1994
Boey SK, Ong BC, Dhara SS: Preoperative plateletpheresis does not reduce blood loss during cardiac surgery. Can J Anaesth 40: 844–850, 1993
Dion I, Lahaye M, Salmon R, Baqey C et al.: Blood haemolysis by ceramics. Biomaterials 14: 107–110, 1993
Karlsson J, Diamant B, Theorell H, Folkers K: Skeletal muscle coenzyme Q10 in healthy man and selected patient groups. In: K Folkers, GP Littarru, T Yamagami (eds). Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier Science Publishers, 1991, pp 191–204
Karlsson J, Sylvén C, Jansson E, Böök K, Muratsu K, Folkers K: Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral disease. Mol Cell Biochem 84: 59–64, 1988
Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K: Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: L Packer, J Fuchs (eds). Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 1993, pp 473–493
Karlsson J, Liska J, Gunnes S et al.: Heart muscle ubiquinone and plasma antioxidants following cardiac transplantation. Clin Invest 71: S76–S83, 1993
Kalén A, Norling B, Appelkvist EL, Dallner G: Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim Biophys Acta 926: 70–78, 1987
Elmberger PG, Kalén A, Appelkvist E-L, Dallner G: In vitroand in vivosynthesis of dolichol and other main mevalonate products in various organs of the rat. Europ J Biochem 168: 1–11, 1987
Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343: 425–430, 1990
Appelkvist E-L, Karlén A, Dallner G: Biosynthesis and regulation of coenzyme Q. In: K Folkers, GP Littarru, T Yamagami (eds). Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991, pp 141–150
Kalén A, Appelkvist EL, Dallner G: Biosynthesis of ubiquinone in rat liver. Acta Chem Scand 41: 70–72, 1987
Karlsson J, Diamant B, Theorell H, Folkers K: Ubiquinone and atocopherol in plasma; Means of translocation or depot. Clin Invest 71: S84–S91, 1993
Bendich A, Gabriel E, Machlin LJ: Dietary vitamin E requirement for optimum immune response in the rat. J Nutr 116: 675–681, 1986
Stocker R, Bowry VW, Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 88: 1646–1650, 1991
Stocker R, Frei B: Endogenous antioxidant defenses in human blood plasma. In: H Sies (ed). Oxidative Stress: Oxidants and Antioxidants. Orlando, Fl: Academic Press, 1991, pp 213–243
Ernster L, Forsmark-Andrée P: Ubiquinol–an endogenous antioxidant in aerobic organisms. Clin Invest 71: S60–S65, 1993
Bowry VW, Mohr D, Cleary J, Stocker R: Prevention of tocopherolmediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 270: 5756–5763, 1995
Mölgaard J, von Schenck H, Olsson AG: Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J 9: 541–551, 1988
Bilheimer DW: Longterm clinical tolerance of lovastatin (Mevalonin) and simvastatin (Epistatin). An overview. Drugs Invest Suppl 2: 58–67, 1990
Folkers K, Langsjoen P, Willis R et al.: Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 87: 8931–8934, 1990
Willis RA, Folkers K, Tucker JL, Xia L-J, Tamagawa H: Lovastatin decreases coenzyme Q levels in rats. Proc Natl Sci USA 87: 8928–8930, 1990
Laaksonen R, Jokelainen K, Sahi T, Tikkanen MJ, Himberg JJ: Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue short-term simvastatin treatment in humans. Clin Pharmacol Ther 57: 62–66, 1995
Ambrosio G, Weisfeldt ML, Jacobus WE, Flaherty JY: Evidence for a reversible radical-mediated component of reperfusion injury: Reduction by recombinant human superoxidae dismutase administered at the time of reflow. Circulation 75: 282–291, 1987
Blake DR, Unsworth J, Outhwaite JM et al.: Hypoxic-reperfusion injury in the inflamed human joint. Lancet 8633: 289–293, 1989
Opie LH: Reperfusion injury and its pharmacological modification. Circulation 80: 1989
Karlsson J: Heart and skeletal muscle ubiquinone or CoQ10 as a protective agent against radical formation in man. In: G Benzi (ed). Advances in Myochemistry. London: John Libbey, 1987, pp 305–318
Karlsson J, Lindh G, Rønneberg R: Smoking, plasma antioxidants and essential fatty acids before and after nutratherapy. Can J Cardiol 12: 571–665, 1996
Leaf DA, Rauch CR: Omega-3 supplementation and estimated VO2max: A double randomized controlled trial in athletes. Ann Sports Med 4: 37–40, 1988
Kamada T, Tokuda S, Aozaki S-I, Otsuji S: Higher levels of erythrocyte membrane fluidity in sprinters and long-distance runners. J Appl Physiol 74: 354–358, 1993
GEIGY: Constituents of living matters–Vitamins. In: C Lentner (ed). Geigy Scientific Tables. Basle: CIBA-GEIGY Limited, 61–70, 1986
Edlund P-O: Determination of coenzyme Q10, ?-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. Journ Chromat 425: 87–97, 1988
Karlsson J, Diamant B, Folkers K, Edlund P-O, Lund B, Theorell H: Plasma ubiquinone and cholesterol contents with and without ubiquinone treatment. In: G Lenaz, O Barnabei, A Rabbi, M Battino (eds). Highlights in Ubiquinone Research. London: Taylor and Francis, 296–302, 1990
Johansen K, Theorell H, Karlsson J, Diamant B, Folkers K: Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann Med 23: 649–656, 1991
Ward PA, Warren JS, Johnson KJ: Oxygen radicals, inflammation and tissue injury. Free Rad Comm 5: 403–408, 1988
Hess ML, Manson NH: Molecular oxygen: Friend and foe. J Mol Cell Cardiol 19: 969–985, 1984
Ernster L, Beyer RE: Antioxidant functions of coenzyme Q: Some biochemical and pathophysiological implications. In: K Folkers, GP Littarru, T Yamagami (eds). Biochemical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 45–58, 1991
Packer L, Kagan VE: Vitamin E: The antioxidant harvesting center of membranes and lipoproteins. In: L Packer, J Fuchs (eds). Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 1993: 179–192
Esterbauer H, Puhl H, Waeg G, Krebs A, Dieber-Rothender M: The role of vitamin E in lipoprotein oxidation. In: L Packer, J Fuchs (eds). Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 649–671, 1993
Kagan V, Serbinova E, Packer L: Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun 169: 851–857, 1990
Elmberger PG, Kalén A, Brunk U, Dallner G: Discharge of newlysynthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids 24: 919–930, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karlsson, J., R¢nneberg, R. & Semb, B. Vitamins Q and E, extracorporal circulation and hemolysis. Mol Cell Biochem 173, 33–41 (1997). https://doi.org/10.1023/A:1006874923181
Issue Date:
DOI: https://doi.org/10.1023/A:1006874923181